(Press-News.org) Cannabis use has been increasing during pregnancy, according to researchers at Columbia University Mailman School of Public Health and the Columbia University Irving Medical Center. Previous research has observed that past-month cannabis use has more than tripled among pregnant women in the U.S. from 2002-2020 with self-reported cannabis use rising from 1.5 percent to 5.4 percent over the 18 years of tracking data. The findings are published in the American Journal of Preventive Medicine.
Medical guidelines recommend that pregnant women abstain from cannabis because of its link to an increased risk of adverse maternal and neonatal outcomes and concerns regarding long-term effects on mental health.
The researchers investigated cannabis use disorder (CUD) diagnoses during pregnancy using data from the MerativeTM Marketscan® Commercial Claims and Encounters Database of pregnant women from 2015- 2020 aged 12-55 with continuous insurance enrollment. The researchers used the International Classification of Diseases codes to identify CUD diagnoses.
Their findings show between 2015-2020, 893,430 pregnant women were identified, resulting in 1,058,448 total pregnancies. The cumulative prevalence of CUD diagnosis was 0.26%, yearly prevalence ranged from 0.22 (2015) to 0.27 (2018 and 2019).
“While earlier research analyzed data from a specific geographic sample of pregnant women, this study aimed to examine the prevalence of CUD diagnosis during pregnancy among a large sample of commercially insured women determined from commercial administrative claims data during a five-year period,” observed Priscila Gonçalves, PhD, assistant professor in the Department of Psychiatry, Columbia University Irving Medical Center, and first author.
Cannabis for medical use was legal in 34 states and Washington DC in 2020 (last year of data included in the study). Although women could be self-medicating during pregnancy through the anti-nausea properties of cannabis, it is also possible that many pregnant women meet criteria for CUD. .
Clinicians who regularly meet with pregnant women are well-positioned to intervene in cannabis use and CUD but might lack the structural support to conduct relevant interventions, according to Goncalves. This is in addition to some women’s fear of legal repercussions related to disclosing substance use that could impede the degree of underestimated CUD diagnoses as well as medically appropriate interventions.
“Our results highlight the need to better understand the determinants of CUD among pregnant women, including factors related to CUD diagnosis – from the severity of CUD -- as well as factors contributing to diagnosis and treatment,” noted Silvia Martins, MD, PhD, professor of Epidemiology at Columbia Mailman School, and senior author of the study. “This study makes it clear that additional research is needed to inform prevention and intervention opportunities.”
Co-authors are Morgan Philbin, University of California San Francisco; Weijia Fan, Megan Marziali, Emilie Bruzelius, Luis Segura, Pia Mauro, Columbia Mailman School of Public Health; and Yongmei Huang, Columbia Mailman School and Columbia University Irving Medical Center.,
The study reported in this press release was supported by the National Institute on Drug Abuse of the National Institutes of Health, under grant numbers R01DA053745, T32DA031099, K01DA057389, R36DA061635, and K01DA045224. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The authors have no financial disclosures to report.
Columbia University Mailman School of Public Health
Founded in 1922, the Columbia University Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Columbia Mailman School is the third largest recipient of NIH grants among schools of public health. Its nearly 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change and health, and public health preparedness. It is a leader in public health education with more than 1,300 graduate students from 55 nations pursuing a variety of master’s and doctoral degree programs. The Columbia Mailman School is also home to numerous world-renowned research centers, including ICAP and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu.
END
Cannabis use disorder among insured pregnant women in the US between 2015-2020
Additional research is needed to inform prevention and intervention
2025-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Education system needs overhaul to support school anxiety, psychologists say
2025-03-30
The UK education system must urgently change to be more understanding of school ‘refusers’, as returning to school might not be the right outcome for some children, psychologists say.
While much has been made of school attendance figures in recent months, a group of experts are suggesting not enough attention has been given to the experiences of parents and young people experiencing school distress.
In a new book, What Can We Do When School’s Not Working?, a parent and two ...
Play “humanizes” pediatric care and should be key feature of a child-friendly NHS – report
2025-03-30
Play should be a core feature of children’s healthcare in forthcoming plans for the future of the NHS, according to a new report which argues that play “humanises” the experiences of child patients.
The report, by University of Cambridge academics for the charity Starlight, calls for play, games and playful approaches to be integrated into a ‘holistic’ model of children’s healthcare – one that acknowledges the emotional and psychological dimensions of good health, ...
Stricter oversight needed as financial misconduct drives risk-taking in banking
2025-03-30
Banks facing regulatory sanctions for financial misconduct tend to adopt riskier business practices, according to new research.
The authors warn repeated or systemic misconduct can accelerate risk-taking in ways that weaken both individual institutions and the wider financial system.
Researchers from the University of East Anglia (UEA), the US Department of the Treasury and Bangor University, in the UK, drew on data from nearly 1,000 publicly listed US banks from 1998 to 2023 - a period spanning multiple economic cycles including the 2007–09 ...
Cardiac arrest during long-distance running races
2025-03-30
About The Study: This study found that despite increased participation in U.S. long distance running races, the incidence of cardiac arrest during U.S. marathons and half-marathons remains stable. There has been a marked decline in cardiac arrest mortality, and coronary artery disease was the most common etiology among cases with sufficient cause-related data. Effective emergency action planning with immediate access to defibrillation may explain the improvement in survival.
Corresponding Authors: To ...
Preventable cardiac deaths during marathons are down, Emory study finds
2025-03-30
While more people than ever are running marathons in the U.S., the risk of dying from a heart attack during a run has fallen dramatically in recent years. That’s a key conclusion from a new study by Jonathan Kim, associate professor in the Emory School of Medicine. Kim’s research is a follow-up to a study he published in 2012 – the first investigation into unexpected cardiac arrests during long distance running events.
The new findings, published in JAMA, indicate that while the rate of marathon runners who suffer cardiac arrests remained unchanged, their chance for survival is twice what it was in the ...
New study finds peripheral artery disease often underdiagnosed and undertreated; opportunity to improve treatments, lower death rates
2025-03-30
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer women getting guideline-directed medical therapy than men.
As a result, combined with this highly debilitating disease, patients with peripheral artery disease have a more than 50 percent chance of dying from the condition.
Peripheral artery disease affects nearly 10 percent of the US population. It occurs when the arteries that carry blood to the legs and arms become narrowed or blocked by plaque ...
Use of antidepressant medication linked to substantial increase in risk of sudden cardiac death
2025-03-30
Vienna, Austria- 30 March 2025
Sudden cardiac death (SCD) refers to an unexpected death of a person, believed to be caused by a heart-related issue. It occurs within one hour of the onset of symptoms in witnessed cases or within 24 hours of the person being last seen alive in unwitnessed cases.
The causes in people under the age of 39 are often a thickening of the heart muscle or an electrical problem with the heart. In older people, SCD is more likely to be caused by a narrowing of the blood vessels that supply the heart.
Previous research has shown1 that patients with psychiatric disorders have an increased all-cause mortality ...
Atrial fibrillation diagnosed in midlife is linked to a 21% increased risk of dementia at any age and a 36% higher risk of early-onset dementia
2025-03-30
Vienna, Austria- 31 March 2025
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future dementia by 21% in patients diagnosed with AF under 70 and the risk of early-onset dementia (diagnosed before age 65 years) by 36%. The association was stronger in younger adults and was lost in older adults aged 70 years and over.
“This is the largest European population-based study evaluating the association between AF and dementia,” say the authors that include Dr Julián Rodriguez ...
Mode of death in patients with heart failure with mildly reduced or preserved ejection fraction
2025-03-30
About The Study: Among patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure randomized clinical trial, higher proportions of cardiovascular and overall mortality in those with ejection fraction less than 50% were related principally to higher proportions of sudden death. A clear treatment effect of finerenone on cardiovascular or cause-specific mortality was not identified, although the trial was likely underpowered for these outcomes.
Corresponding Author: To contact the corresponding author, Akshay S. Desai, ...
Intravenous ferric carboxymaltose in heart failure with iron deficiency
2025-03-30
About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or in patients with a transferrin saturation less than 20%, or reduce the total number of heart failure hospitalizations vs placebo.
Corresponding Author: To contact the corresponding author, Stefan D. Anker, MD, PhD, email s.anker@cachexia.de.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.3833)
Editor’s ...
LAST 30 PRESS RELEASES:
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet
Balance between two competing nerve proteins deters symptoms of autism in mice
Use of antifungals in agriculture may increase resistance in an infectious yeast
Awareness grows of cancer risk from alcohol consumption, survey finds
The experts that can outsmart optical illusions
Pregnancy may reduce long COVID risk
Scientists uncover novel immune mechanism in wheat tandem kinase
Three University of Virginia Engineering faculty elected as AAAS Fellows
Unintentional drug overdoses take a toll across the U.S. unequally, study finds
A step toward plant-based gelatin
ECMWF unveils groundbreaking ML tool for enhanced fire prediction
The food and fuel that farms itself
Patient- and Community-Level Characteristics Associated With RSV Vaccination
Intersectional Racial and Sex Disparities in Unintentional Overdose Mortality
PLOS announces new partnership in China
New options for controlling type 2 diabetes
Senolytics target Alzheimer’s-linked brain enzymes without harming healthy ones
An immune cell may explain how maternal inflammation causes neurodevelopmental disorder
New study refocuses research on mysterious falcon decline
Omega-6 fatty acid promotes the growth of an aggressive type of breast cancer
[Press-News.org] Cannabis use disorder among insured pregnant women in the US between 2015-2020Additional research is needed to inform prevention and intervention